About the Journal:

The Annals of Infection and Drug Resistance is an international, peer-reviewed journal dedicated to publishing high-quality research on infectious diseases and antimicrobial resistance. The journal focuses on advancing scientific understanding, clinical management, and prevention strategies related to infections and the growing global challenge of drug resistance.

It provides a platform for researchers, clinicians, microbiologists, and public health professionals to share innovative findings, emerging trends, and evidence-based practices aimed at improving patient outcomes and controlling the spread of resistant pathogens.

Scope of the Journal

The journal welcomes original research and scholarly contributions in areas including, but not limited to:

• Infectious Diseases (bacterial, viral, fungal, and parasitic)

• Antimicrobial and Antibiotic Resistance

• Clinical Microbiology

• Epidemiology of Infectious Diseases

• Infection Prevention and Control

• Antimicrobial Stewardship

• Drug Development and Novel Therapeutics

• Vaccines and Immunization

• Molecular Diagnostics and Genomics

• Hospital-Acquired Infections (HAIs)

• Global Health and Emerging Infections

Aims and Objectives

• To disseminate cutting-edge research on infections and drug resistance

• To address the global burden of antimicrobial resistance (AMR)

• To promote interdisciplinary collaboration in infection control and treatment

• To support development of new therapeutic and preventive strategies

Types of Articles Accepted

Original Research Articles, Review Articles, Case Reports and Case Series, Short Communications, Clinical Studies, Perspectives and Commentaries

Target Audience

• Infectious Disease Specialists

• Microbiologists and Virologists

• Pharmacologists and Drug Researchers

• Healthcare Professionals and Clinicians

• Public Health Experts

• Academic Researchers and Students.